COVID Steroid 2 compares high versus low dose dexamethasone (a steroid) for the treatment of patients with COVID-19.
Dexamethasone has shown promise as a potential treatment for COVID-19. With this trial we aim to see which dose is most effective for critically ill patients.
Trial Sponsor
Professor, MD, Anders Perner
University Hospital Copenhagen, Rigshospitalet
anders.perner@regionh.dk
Useful Documents
- Information for patients (English)
- Read the latest COVID Steroid 2 newsletter
- COVID Steroid 2 trial publications
Overview of Recruitment